Professor Giovanna Mallucci

Giovanna Mallucci

University position


Professor Giovanna Mallucci is pleased to consider applications from prospective PhD students.


Department of Clinical Neurosciences


Home page

Research Themes

Cellular and Molecular Neuroscience

Clinical and Veterinary Neuroscience


My lab is interested in understanding mechanisms of neurodegeneration. The central theme is the identification of common pathways across the spectrum of these disorders (which include Alzheimer's and related diseases) that are relevant for both mechanistic insights and therapy. We focus both on ‘toxic’ processes that can be targeted to prevent neuronal death, and on regenerative processes that can be harnessed for repair. Using mouse models, we described the pathogenic role of the unfolded protein response (UPR) in neurodegeneration, which led to the discovery of the first small molecule - an inhibitor of this pathway - to prevent neurodegeneration in vivo. We also recently discovered the phenomenon of failure of synaptic repair processes in neurodegeneration and the underlying mechanisms: failure of another stress response involving 'cold shock' proteins, which we have successfully harnessed for neuroprotection. We aim to translate this research for new treatments for dementia.

mechanisms of neurodegeneration and synaptic regeneration
mechanisms of neurodegeneration and synaptic regeneration
View image full-size (5683x4183 pixels)

Research Focus



Alzheimer's disease

unfolded protein response

structural plasticity

translational research

Clinical conditions

Alzheimer's disease


prion diseases

protein misfolding neurodegenerative disorders


No equipment indicated



Franklin Aigbirhio

Tim Fryer

John O'Brien

David Ron

United Kingdom

David Barrett Web:

Richard Bayliss Web:

Martin Bushell Web:

Peter Fischer Web:

Anne Willis Web:


Jeffery Axten Web:

Akihiro Kusumi Web:

Associated News Items

Key publications

Peretti D, Bastide A, Radford H, Verity N, Molloy C, Martin MG, Moreno JA, Steinert JR, Smith T, Dinsdale D, Willis AE, Mallucci GR (2015), “RBM3 mediates structural plasticity and protective effects of cooling in neurodegeneration.” Nature 518(7538):236-9 PDF Details

Moreno JA, Halliday M, Molloy C, Radford H, Verity N, Axten JM, Ortori CA, Willis AE, Fischer PM, Barrett DA, Mallucci GR (2013), “Oral treatment targeting the unfolded protein response prevents neurodegeneration and clinical disease in prion-infected mice.” Sci Transl Med 5(206):206ra138 PDF Details

Moreno JA, Radford H, Peretti D, Steinert JR, Verity N, Martin MG, Halliday M, Morgan J, Dinsdale D, Ortori CA, Barrett DA, Tsaytler P, Bertolotti A, Willis AE, Bushell M, Mallucci GR (2012), “Sustained translational repression by eIF2α-P mediates prion neurodegeneration.” Nature 485(7399):507-11 PDF Details



Halliday M, Mallucci GR (2015), “Review: Modulating the unfolded protein response to prevent neurodegeneration and enhance memory.” Neuropathol Appl Neurobiol 41(4):414-27 PDF Details

Halliday M, Radford H, Sekine Y, Moreno J, Verity N, le Quesne J, Ortori CA, Barrett DA, Fromont C, Fischer PM, Harding HP, Ron D, Mallucci GR (2015), “Partial restoration of protein synthesis rates by the small molecule ISRIB prevents neurodegeneration without pancreatic toxicity.” Cell Death Dis 6:e1672 PDF Details


Brinkmalm A, Brinkmalm G, Honer WG, Moreno JA, Jakobsson J, Mallucci GR, Zetterberg H, Blennow K, Öhrfelt A (2014), “Targeting synaptic pathology with a novel affinity mass spectrometry approach.” Mol Cell Proteomics 13(10):2584-92 Details

Halliday M, Mallucci GR (2014), “Targeting the unfolded protein response in neurodegeneration: A new approach to therapy.” Neuropharmacology 76 Pt A:169-74 PDF Details

Halliday M, Radford H, Mallucci GR (2014), “Prions: generation and spread versus neurotoxicity.” J Biol Chem 289(29):19862-8 Details

Tufi R, Gandhi S, de Castro IP, Lehmann S, Angelova PR, Dinsdale D, Deas E, Plun-Favreau H, Nicotera P, Abramov AY, Willis AE, Mallucci GR, Loh SH, Martins LM (2014), “Enhancing nucleotide metabolism protects against mitochondrial dysfunction and neurodegeneration in a PINK1 model of Parkinson's disease.” Nat Cell Biol 16(2):157-66 PDF Details


Dhiraj DK, Chrysanthou E, Mallucci GR, Bushell M (2013), “miRNAs-19b, -29b-2* and -339-5p show an early and sustained up-regulation in ischemic models of stroke.” PLoS One 8(12):e83717 Details

Halliez S, Chesnais N, Mallucci G, Vilotte M, Langevin C, Jaumain E, Laude H, Vilotte JL, Béringue V (2013), “Targeted knock-down of cellular prion protein expression in myelinating Schwann cells does not alter mouse prion pathogenesis.” J Gen Virol 94(Pt 6):1435-40 Details

Mallucci G (2013), “Spreading proteins in neurodegeneration: where do they take us?” Brain 136(Pt 4):994-5 Details


Verity NC, Mallucci GR (2011), “Rescuing neurons in prion disease.” Biochem J 433(1):19-29 Details


Moreno JA, Mallucci GR (2010), “Dysfunction and recovery of synapses in prion disease: implications for neurodegeneration.” Biochem Soc Trans 38(2):482-7 Details

Radford HE, Mallucci GR (2010), “The role of GPI-anchored PrP C in mediating the neurotoxic effect of scrapie prions in neurons.” Curr Issues Mol Biol 12(2):119-27 Details


Mallucci GR (2009), “Can mutations of prion protein shed light on its normal function?” J Neurol Neurosurg Psychiatry 80(12):1303 Details

Mallucci GR (2009), “Prion neurodegeneration: starts and stops at the synapse.” Prion 3(4):195-201 Details

White MD, Mallucci GR (2009), “RNAi for the treatment of prion disease: a window for intervention in neurodegeneration?” CNS Neurol Disord Drug Targets 8(5):342-52 Details

White MD, Mallucci GR (2009), “Therapy for prion diseases: Insights from the use of RNA interference.” Prion 3(3):121-8 Details


White MD, Farmer M, Mirabile I, Brandner S, Collinge J, Mallucci GR (2008), “Single treatment with RNAi against prion protein rescues early neuronal dysfunction and prolongs survival in mice with prion disease.” Proc Natl Acad Sci U S A 105(29):10238-43 PDF Details


Mallucci GR, White MD, Farmer M, Dickinson A, Khatun H, Powell AD, Brandner S, Jefferys JG, Collinge J (2007), “Targeting cellular prion protein reverses early cognitive deficits and neurophysiological dysfunction in prion-infected mice.” Neuron 53(3):325-35 PDF Details


Nassar MA, Baker MD, Levato A, Ingram R, Mallucci G, McMahon SB, Wood JN (2006), “Nerve injury induces robust allodynia and ectopic discharges in Nav1.3 null mutant mice.” Mol Pain 2:33 Details


Mallucci G, Collinge J (2005), “Rational targeting for prion therapeutics.” Nat Rev Neurosci 6(1):23-34 PDF Details


Mallucci G, Collinge J (2004), “Update on Creutzfeldt-Jakob disease.” Curr Opin Neurol 17(6):641-7 Details


Mallucci G, Dickinson A, Linehan J, Klöhn PC, Brandner S, Collinge J (2003), “Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis.” Science 302(5646):871-4 PDF Details


Mallucci GR, Ratté S, Asante EA, Linehan J, Gowland I, Jefferys JG, Collinge J (2002), “Post-natal knockout of prion protein alters hippocampal CA1 properties, but does not result in neurodegeneration.” EMBO J 21(3):202-10 PDF Details


Mallucci GR, Campbell TA, Dickinson A, Beck J, Holt M, Plant G, de Pauw KW, Hakin RN, Clarke CE, Howell S, Davies-Jones GA, Lawden M, Smith CM, Ince P, Ironside JW, Bridges LR, Dean A, Weeks I, Collinge J (1999), “Inherited prion disease with an alanine to valine mutation at codon 117 in the prion protein gene.” Brain 122 ( Pt 10):1823-37 Details